Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4806990> ?p ?o }
Showing triples 1 to 38 of
38
with 100 triples per page.
- Q4806990 subject Q8220082.
- Q4806990 subject Q8570773.
- Q4806990 subject Q8808791.
- Q4806990 subject Q9134654.
- Q4806990 abstract "Asimadoline (EMD-61753) is a drug which acts as a peripherally selective κ-opioid receptor (KOR) agonist. Because of its poor ability to cross the blood–brain barrier, asimadoline lacks the psychotomimetic effects of centrally acting KOR agonists, and consequently has more potential for medical use, and has been researched as a possible treatment for irritable bowel syndrome, with reasonable efficacy seen in clinical trials.".
- Q4806990 atcPrefix "none".
- Q4806990 casNumber "153205-46-0".
- Q4806990 fdaUniiCode "D0VK52NV5M".
- Q4806990 iupacName "N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide".
- Q4806990 pubchem "179340".
- Q4806990 thumbnail Asimadoline_structure.png?width=300.
- Q4806990 wikiPageWikiLink Q14897645.
- Q4806990 wikiPageWikiLink Q20539232.
- Q4806990 wikiPageWikiLink Q221694.
- Q4806990 wikiPageWikiLink Q2569888.
- Q4806990 wikiPageWikiLink Q30612.
- Q4806990 wikiPageWikiLink Q389934.
- Q4806990 wikiPageWikiLink Q5441133.
- Q4806990 wikiPageWikiLink Q6960874.
- Q4806990 wikiPageWikiLink Q7256512.
- Q4806990 wikiPageWikiLink Q8220082.
- Q4806990 wikiPageWikiLink Q838966.
- Q4806990 wikiPageWikiLink Q8570773.
- Q4806990 wikiPageWikiLink Q8808791.
- Q4806990 wikiPageWikiLink Q9134654.
- Q4806990 atcPrefix "none".
- Q4806990 casNumber "153205".
- Q4806990 iupacName "N-[-2-[-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide".
- Q4806990 pubchem "179340".
- Q4806990 unii "D0VK52NV5M".
- Q4806990 type ChemicalSubstance.
- Q4806990 type Drug.
- Q4806990 type ChemicalObject.
- Q4806990 type Thing.
- Q4806990 type Q8386.
- Q4806990 comment "Asimadoline (EMD-61753) is a drug which acts as a peripherally selective κ-opioid receptor (KOR) agonist. Because of its poor ability to cross the blood–brain barrier, asimadoline lacks the psychotomimetic effects of centrally acting KOR agonists, and consequently has more potential for medical use, and has been researched as a possible treatment for irritable bowel syndrome, with reasonable efficacy seen in clinical trials.".
- Q4806990 label "Asimadoline".
- Q4806990 depiction Asimadoline_structure.png.